Hypericum perforatum extracts as potential antidepressants (Q33690247)

28 July 2017

1 reference

title

Hypericum perforatum extracts as potential antidepressants (English)

1 reference

28 July 2017

Hypericum perforatum

1 reference

Vitiello B

1

1 reference

28 July 2017

publication date

1 May 1999

1 reference

Journal of Pharmacy and Pharmacology

28 July 2017

published in

1 reference

28 July 2017

volume

51

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

513-517

1 reference

Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

Hypericin and Pseudohypericin: Pharmacokinetics and Effects on Photosensitivity in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

Antidepressant Activity of Hypericum Perforatum and Hyperforin: the Neglected Possibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

In VitroReceptor Binding and Enzyme Inhibition byHypericum perforatumExtract

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

St. John's Wort in Mild to Moderate Depression: The Relevance of Hyperforin for the Clinical Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

Effects of Hypericum Extract (LI 160) in Biochemical Models of Antidepressant Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

Hyperforin Represents the Neurotransmitter Reuptake Inhibiting Constituent of Hypericum Extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

Biologically Active and Other Chemical Constituents of the Herb of Hypericum perforatum L

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

Solubilized Hypericin and Pseudohypericin fromHypericum perforatumExert Antidepressant Activity in the Forced Swimming Test3

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

The Effect of Hypericum Extract on Cardiac Conduction as seen in the Electrocardiogram Compared to that of Imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

Efficacy and Tolerability of St. John's Wort Extract LI 160 Versus Imipramine in Patients with Severe Depressive Episodes According to ICD-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

Pharmaceutical quality of hypericum extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

LI 160, an Extract of St. John's Wort, Versus Amitriptyline in Mildly to Moderately Depressed Outpatients - A Controlled 6-Week Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1211/0022357991772781

Pharmaceutical Quality of Hypericum Extracts

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1177/089198879400701S18

Pharmacokinetics of Hypericin and Pseudohypericin after Oral Intake of the Hypericum Perforatum Extract LI 160 in Healthy Volunteers

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1177/089198879400701S13

Identifiers

DOI

10.1211/0022357991772781

1 reference

28 July 2017

1 reference